Form 4: Bicara Therapeutics Director Acquires Stock Options
SEC Form 4 Filing
Director Scott M. Robertson acquires stock options in Bicara Therapeutics.
Summary
- On September 12, 2024, Scott M. Robertson, a director of Bicara Therapeutics Inc. [BCAX], acquired 23,746 stock options.
- The exercise price of these options is $18.
- The options vest upon the earlier of August 16, 2025, or the date of the next Annual Meeting of Stockholders, contingent on continued service.
- The options expire on September 12, 2034.
- Following the transaction, Robertson directly owns 23,746 derivative securities.
Sentiment
Score: 5
Explanation: Neutral sentiment as it's a standard disclosure of stock option acquisition by a director.
Industry Context
This is a standard SEC Form 4 filing, reflecting a change in beneficial ownership by a company insider. Such filings are common and provide transparency into the transactions of company directors and officers.
Stakeholder Impact
- The acquisition of stock options by a director can be viewed positively by shareholders as it aligns the director's interests with the company's long-term success.
Key Dates
| Date | Description |
|---|---|
| 09/12/2024 | Date of transaction: Director acquired stock options. |
| 08/16/2025 | Earliest vesting date for the stock options. |
| 09/12/2034 | Expiration date of the stock options. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.